Yttrium-90

src: i.ytimg.com

Yttrium-90, 90
Y
, is a medically significant isotope of yttrium. Yttrium-90 has a wide and valuable use in radiation therapy to treat cancer.

Video Yttrium-90

Decay

90
Y
undergoes ?^- decay to zirconium-90 with a half-life of 64.1 hours and a decay energy of 2.28 MeV. It also produces 0.01% 1.7 MeV photons along the way. Interaction of the emitted electrons with matter can lead to Bremsstrahlung radiation.

Maps Yttrium-90

Production

Yttrium-90 is a decay product of strontium-90 which makes up about 5% of the nuclear daughter isotopes when uranium is fissioned. Yttrium-90 is produced by chemical high-purity separation from strontium-90, a fission product of uranium in nuclear reactors.

src: www.frontiersin.org

Clinical Application

⁹⁰Y plays a significant role in the treatment of hepatocellular carcinoma (HCC) and other liver cancers. Trans-arterial radioembolization is a procedure performed by interventional radiologists in which microspheres are impregnated with ⁹⁰Y and injected into the arteries supplying the tumor. Radioembolization with ⁹⁰Y significantly increases time-to-progression (TTP) of HCC, has a tolerable adverse event profile, and improves patient quality of life more than do similar therapies.

src: www.frontiersin.org

See also

• Isotopes of yttrium
• Unsealed source radiotherapy

src: www.mediray.gr

References

src: cancerres.aacrjournals.org

External links

• CID {{{1}}} from PubChem

Source of the article : Wikipedia